Skip to main content
. 2018 Jan 31;55(6):1–11. doi: 10.1136/jmedgenet-2017-105127

Figure 2.

Figure 2

Penetrance of clinical disease in SDHB mutation carriers by age 60 years, as calculated by different statistical techniques and in different subpopulations. HNPGL,  head and neck paraganglioma; PPGL, phaeochromocytoma and paraganglioma; RCC, renal cell carcinoma.